Jeffrey T. Macher
Ph.D., Business Economics, University of California, Berkeley
- Economics of Technology and Innovation
- Industry Structure
- Competitive Strategy
Jeffrey T. Macher is a professor of strategy, economics, and public policy in the McDonough School of Business at Georgetown University. He also is the academic director of Georgetown’s Center for Business and Public Policy. He teaches full-time, evening, and executive MBA and executive education courses in microeconomics, competitive and corporate strategy, and the management of technology and innovation.
Macher received his BSE in computer engineering from the College of Engineering at the University of Michigan; his MBA from the Amos Tuck School of Business Administration at Dartmouth College; and his Ph.D. from the Walter A. Haas School of Business at the University of California, Berkeley. Prior to Georgetown University, he worked for Braxton Associates, a strategy consulting firm now part of Deloitte Consulting, IBM, and Motorola.
Macher examines the intersection of strategy, economics, and innovation. His research interests include industry structure, regulation, competitive strategy, and the organization and economics of innovation in a variety of high technology industries, including biopharmaceuticals, medical devices, and semiconductors. His research has been published in Academy of Management Journal, B.E. Journal of Economic Analysis and Policy, California Management Review, Journal of Law and Economics, Journal of Regulatory Economics, Management Science, Organization Science, and Strategic Management Journal, among others. He is the co-editor of a book entitled, Innovation in Global Industries: U.S. Firms Competing in a New World, published in 2008 by the National Academy Press.
He is a member of the Academy of Management (AOM), the International Society for New Institutional Economics (ISNIE), and the Strategic Management Society (SMS). He is on the editorial boards of Production and Operations Management Journal and Strategic Management Journal, and is a reviewer for several academic journals. He also is a special government employee (SGE) of the Food and Drug Administration (FDA).